A biotechnology company manufacturing therapeutic pharmaceuticals for treating cancer, kidney disease, cardiovascular disease, multiple sclerosis, and other diseases.

Would it be accurate and relevant to link the text highlighted below to the topic Atlantic CanadaAtlantic Canada?

On March 12, 2019 BioVectra announced receiving $37.5 million from The Government of Canada's Strategic Innovation Fund. The investment was the largest investment made by the Strategic Innovation Fund in Atlantic Canada. At the time of receiving funding, the company also announced a five year $144.6 million expansion project to increase the biopharmaceutical production capabilities of facilities in Charlottetown, Prince Edward Island and Windsor, Nova Scotia. 

This text snippet is from the topic BioVectraBioVectra